Cargando…

Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals

The majority of antimicrobials that are produced are administered to animals, particularly food animals. While the overall impact of antimicrobial use in animals on antimicrobial resistance in humans and the environment is unclear, it undeniably has a role. Yet, some degree of antimicrobial use in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott Weese, J., Da Costa Junior, Guilherme Antonio, Gonzalez-Zorn, Bruno, Hardefeldt, Laura Y., Matheu, Jorge, Moulin, Gerard, Page, Stephen W., Singh, Ruby, Song, Junxia, Valsson, Olafur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009376/
https://www.ncbi.nlm.nih.gov/pubmed/36889346
http://dx.doi.org/10.1017/jme.2022.80
_version_ 1784905971152191488
author Scott Weese, J.
Da Costa Junior, Guilherme Antonio
Gonzalez-Zorn, Bruno
Hardefeldt, Laura Y.
Matheu, Jorge
Moulin, Gerard
Page, Stephen W.
Singh, Ruby
Song, Junxia
Valsson, Olafur
author_facet Scott Weese, J.
Da Costa Junior, Guilherme Antonio
Gonzalez-Zorn, Bruno
Hardefeldt, Laura Y.
Matheu, Jorge
Moulin, Gerard
Page, Stephen W.
Singh, Ruby
Song, Junxia
Valsson, Olafur
author_sort Scott Weese, J.
collection PubMed
description The majority of antimicrobials that are produced are administered to animals, particularly food animals. While the overall impact of antimicrobial use in animals on antimicrobial resistance in humans and the environment is unclear, it undeniably has a role. Yet, some degree of antimicrobial use in animals is necessary for animal health and welfare purposes. Balancing the benefits and risks of antimicrobial use in animals is challenging because of the complexity of the problem and limitations in available data. However, a range of measures can be implemented to reduce, refine and optimize antimicrobial use in animals, with a goal of minimizing the impact on human and environmental health while maintaining necessary therapeutic use in animals. A pandemic instrument can provide the necessary foundation for the whole-of-society and whole-of government One Health approach that is required to strengthen surveillance, communication, collaboration, and action.
format Online
Article
Text
id pubmed-10009376
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-100093762023-03-14 Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals Scott Weese, J. Da Costa Junior, Guilherme Antonio Gonzalez-Zorn, Bruno Hardefeldt, Laura Y. Matheu, Jorge Moulin, Gerard Page, Stephen W. Singh, Ruby Song, Junxia Valsson, Olafur J Law Med Ethics Symposium Articles The majority of antimicrobials that are produced are administered to animals, particularly food animals. While the overall impact of antimicrobial use in animals on antimicrobial resistance in humans and the environment is unclear, it undeniably has a role. Yet, some degree of antimicrobial use in animals is necessary for animal health and welfare purposes. Balancing the benefits and risks of antimicrobial use in animals is challenging because of the complexity of the problem and limitations in available data. However, a range of measures can be implemented to reduce, refine and optimize antimicrobial use in animals, with a goal of minimizing the impact on human and environmental health while maintaining necessary therapeutic use in animals. A pandemic instrument can provide the necessary foundation for the whole-of-society and whole-of government One Health approach that is required to strengthen surveillance, communication, collaboration, and action. Cambridge University Press 2022 /pmc/articles/PMC10009376/ /pubmed/36889346 http://dx.doi.org/10.1017/jme.2022.80 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Symposium Articles
Scott Weese, J.
Da Costa Junior, Guilherme Antonio
Gonzalez-Zorn, Bruno
Hardefeldt, Laura Y.
Matheu, Jorge
Moulin, Gerard
Page, Stephen W.
Singh, Ruby
Song, Junxia
Valsson, Olafur
Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals
title Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals
title_full Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals
title_fullStr Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals
title_full_unstemmed Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals
title_short Governance Processes and Challenges for Reservation of Antimicrobials Exclusively for Human Use and Restriction of Antimicrobial Use in Animals
title_sort governance processes and challenges for reservation of antimicrobials exclusively for human use and restriction of antimicrobial use in animals
topic Symposium Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009376/
https://www.ncbi.nlm.nih.gov/pubmed/36889346
http://dx.doi.org/10.1017/jme.2022.80
work_keys_str_mv AT scottweesej governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT dacostajuniorguilhermeantonio governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT gonzalezzornbruno governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT hardefeldtlauray governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT matheujorge governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT moulingerard governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT pagestephenw governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT singhruby governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT songjunxia governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals
AT valssonolafur governanceprocessesandchallengesforreservationofantimicrobialsexclusivelyforhumanuseandrestrictionofantimicrobialuseinanimals